Label: NP THYROID- thyroid tablets tablet
- NDC Code(s): 17224-505-30
- Packager: Calvin Scott & Co Inc.
- This is a repackaged label.
- Source NDC Code(s): 42192-328
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated August 10, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- DOSAGE & ADMINISTRATION
- WARNINGS
- INACTIVE INGREDIENT
- INDICATIONS & USAGE
- PURPOSE
- ACTIVE INGREDIENT
- KEEP OUT OF REACH OF CHILDREN
- NDC 17224-505-30
-
INGREDIENTS AND APPEARANCE
NP THYROID
thyroid tablets tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:17224-505(NDC:42192-328) Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LEVOTHYROXINE (UNII: Q51BO43MG4) (LEVOTHYROXINE - UNII:Q51BO43MG4) LEVOTHYROXINE 76 ug LIOTHYRONINE (UNII: 06LU7C9H1V) (LIOTHYRONINE - UNII:06LU7C9H1V) LIOTHYRONINE 18 ug Inactive Ingredients Ingredient Name Strength MINERAL OIL (UNII: T5L8T28FGP) CALCIUM STEARATE (UNII: 776XM7047L) MALTODEXTRIN (UNII: 7CVR7L4A2D) DEXTROSE MONOHYDRATE (UNII: LX22YL083G) Product Characteristics Color brown (LIGHT BROWN,AS PER LABEL) Score no score Shape ROUND (STANDARD ROUND TABLET) Size 8mm Flavor Imprint Code AP;328 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:17224-505-30 30 in 1 BOTTLE; Type 0: Not a Combination Product 08/01/2025 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 08/01/2025 Labeler - Calvin Scott & Co Inc. (073404626) Establishment Name Address ID/FEI Business Operations Calvin Scott & Co Inc. 073404626 repack(17224-505)
